Comment
doi: 10.1056/NEJM200310233491719.
Bevacizumab in renal-cell cancer
- PMID: 14573745
- DOI: 10.1056/NEJM200310233491719
Item in Clipboard
Comment
Bevacizumab in renal-cell cancer
N Engl J Med.
.
No abstract available
Comment on
-
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.N Engl J Med. 2003 Jul 31;349(5):427-34. doi: 10.1056/NEJMoa021491. N Engl J Med. 2003. PMID: 12890841 Free PMC article. Clinical Trial.
Similar articles
-
In focus: bevacizumab for renal cell carcinoma.Clin Adv Hematol Oncol. 2005 Jan;3(1):68-9. Clin Adv Hematol Oncol. 2005. PMID: 16166971 No abstract available.
-
Combination therapy in patients with metastatic renal cell carcinoma.Clin Adv Hematol Oncol. 2010 Oct;8(10):665-6. Clin Adv Hematol Oncol. 2010. PMID: 21317861 No abstract available.
-
Bevacizumab for renal cell carcinoma, glioblastoma, and other solid tumors.Oncology (Williston Park). 2009 Oct;23(11 Suppl Nurse Ed):54-6. Oncology (Williston Park). 2009. PMID: 19856612 No abstract available.
-
Bevacizumab in combination with IFN-α in metastatic renal cell carcinoma: the AVOREN trial.Expert Rev Anticancer Ther. 2012 Oct;12(10):1253-61. doi: 10.1586/era.12.103. Epub 2012 Nov 8. Expert Rev Anticancer Ther. 2012. PMID: 23136836 Review.
-
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.Clin Ther. 2006 Nov;28(11):1779-802. doi: 10.1016/j.clinthera.2006.11.015. Clin Ther. 2006. PMID: 17212999 Review.
Cited by
-
Therapeutic monoclonal antibodies for multiple myeloma: an update and future perspectives.Am J Blood Res. 2011 Jun 15;1(1):22-33. Am J Blood Res. 2011. PMID: 22065141 Free PMC article.
-
Targeting cell surface β2 -microglobulin by pentameric IgM antibodies.Br J Haematol. 2011 Jul;154(1):111-21. doi: 10.1111/j.1365-2141.2011.08714.x. Epub 2011 May 9. Br J Haematol. 2011. PMID: 21554263 Free PMC article.
-
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.J Clin Invest. 2007 Oct;117(10):2766-77. doi: 10.1172/JCI32479. J Clin Invest. 2007. PMID: 17909625 Free PMC article.
-
Anti-angiogenesis approach to genitourinary cancer treatment.Update Cancer Ther. 2009;3(4):182-188. doi: 10.1016/j.uct.2009.05.002. Update Cancer Ther. 2009. PMID: 19774201 Free PMC article.
-
Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12018-23. doi: 10.1073/pnas.1301331110. Epub 2013 Jul 1. Proc Natl Acad Sci U S A. 2013. PMID: 23818623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
